Rates and predictors of cardiovascular and non‐cardiovascular outcomes in heart failure with preserved ejection fraction

Author:

Shahim Angiza1ORCID,Donal Erwan23,Hage Camilla14,Oger Emmanuel5,Savarese Gianluigi14,Persson Hans67,Haugen‐Löfman Ida14,Ennezat Pierre‐Vladimir8,Sportouch‐Dukhan Catherine9,Drouet Elodie10,Daubert Jean‐Claude23,Linde Cecilia14,Lund Lars H.14,

Affiliation:

1. Division of Cardiology, Department of Medicine Karolinska Institutet Stockholm Sweden

2. Département de Cardiologie & CIC‐IT U 804 Centre Hospitalier Universitaire de Rennes Rennes France

3. LTSI Université Rennes 1, INSERM Rennes France

4. Heart, Vascular and Neuro Theme Karolinska University Hospital Stockholm Sweden

5. Pharmacoepidemiology and Health Services Research, REPERES University of Rennes Rennes France

6. Department of Clinical Sciences Danderyd Hospital, Karolinska Institutet Stockholm Sweden

7. Department of Cardiology Danderyd Hospital Stockholm Sweden

8. Service de Cardiologie CHU Lille France

9. Département de Cardiologie CHU Montpellier Montpellier France

10. Société Française de Cardiologie Paris France

Abstract

AbstractAimsThe detailed sub‐categories of death and hospitalization, and the impact of comorbidities on cause‐specific outcomes, remain poorly understood in heart failure (HF) with preserved ejection fraction (HFpEF). We sought to evaluate rates and predictors of cardiovascular (CV) and non‐CV outcomes in HFpEF.MethodsThe Karolinska–Rennes study was a bi‐national prospective observational study designed to characterize HFpEF (ejection fraction ≥45%). Patients were followed for cause‐specific death and hospitalization. Baseline characteristics were pre‐selected based on clinical relevance and potential eligibility criteria for HFpEF trials. The associations between characteristics and cause‐specific outcomes were assessed with univariable and multivariable Cox regressions.ResultsFive hundred thirty‐nine patients [56% females; median (inter‐quartile range) age 79 (72–84) years; NT‐proBNP/BNP 2448 (1290–4790)/429 (229–805) ng/L] were included. Over 1196 patient‐years follow‐up [median (min, max) 744 days (13–1959)], there were 159 (29%) deaths (13 per 100 patient‐years: CV 5.1 per 100, dominated by HF 3.9 per 100; and non‐CV 5.8 per 100, dominated by cancer, 2.3 per 100). There were 723 hospitalizations in 338 patients (63%; 60 per 100 patient‐years: CV 33 per 100, dominated by HF 17 per 100; and non‐CV 27 per 100, dominated by lung disease 5 per 100).Higher age and natriuretic peptides, lower serum natraemia and NYHA class III–IV were independent predictors of CV death; lower serum natraemia, anaemia and stroke of non‐CV death; and anaemia and lower serum natraemia of non‐CV death or hospitalizations. There were no apparent predictors of CV death or hospitalization.ConclusionsIn a clinical cohort hospitalized and diagnosed with HFpEF, death and hospitalization rates were roughly similar for CV and non‐CV causes. CV deaths were predicted primarily by severity of HF; non‐CV deaths primarily by anaemia and prior stroke. Lower serum sodium predicted both. Hospitalizations were difficult to predict.

Funder

Fédération Française de Cardiologie

Medtronic Europe

Vetenskapsrådet

Hjärt-Lungfonden

Stockholms Läns Landsting

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3